ELOX · Categories · Form 4

ELOX - SEC Form 4 insider transactions

Eloxx Pharmaceuticals Inc. (ELOX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ELOX

• 5d
  Large owner Coastlands Capital Lp disposed of 1,250,000 shares (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 26d
  Director Rubin Steven D converted options into 1,875 shares, increasing direct ownership by 15% to 14,625 units (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 26d
  President and CEO Aggarwal Sumit exercised 472,826 shares at a strike of $0.08 and was granted 1,000,000 shares, increasing direct ownership by 737% to 1,672,756 units (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 26d
  Director Walts Alan Edmund converted options into 1,875 shares, increasing direct ownership by 14% to 15,567 units (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 594d
  Director Walts Alan Edmund was granted 12,000 shares, increasing direct ownership by 1,274% to 12,942 units (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 594d
  Director Androski Lindsay was granted 12,000 shares (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 594d
  Director Rubin Steven D was granted 12,000 shares (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 594d
  PRESIDENT AND CEO Aggarwal Sumit was granted 165,000 shares, increasing direct ownership by 3,347% to 169,930 units (SEC Form 4)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 859d
  SEC Form 4 filed by Walts Alan Edmund

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 859d
  SEC Form 4 filed by Rubin Steven D

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 859d
  SEC Form 4 filed by Androski Lindsay

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 859d
  SEC Form 4 filed by Aggarwal Sumit

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1219d
  SEC Form 4 filed by Walts Alan Edmund

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1219d
  SEC Form 4 filed by Rubin Steven D

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1219d
  SEC Form 4 filed by Kariv Tomer

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1219d
  SEC Form 4 filed by Androski Lindsay

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1223d
  SEC Form 4 filed by Aggarwal Sumit

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1223d
  SEC Form 4 filed by Modur Vijay

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1428d
  SEC Form 4 filed by Androski Lindsay

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Walts Alan Edmund

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Veinrib Gadi

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Seehra Jasbir

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Rubin Steven D

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Parekh Rajesh B

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Nussbaum Ran

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Kariv Tomer

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1447d
  SEC Form 4 filed by Avnur Zafrira

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1643d
  SEC Form 4: Walts Alan Edmund converted options into 37,695 shares

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1643d
  SEC Form 4: Aggarwal Sumit covered exercise/tax liability with 81,933 shares and converted options into 279,158 shares

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1643d
  SEC Form 4: Modur Vijay converted options into 219,326 shares and covered exercise/tax liability with 64,373 shares

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1645d
  SEC Form 4: Geffken Daniel E. bought $36,000 worth of shares (50,000 units at $0.72)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1769d
  SEC Form 4: Belloff Neil S. converted options into 1,563 units of Common Stock and covered exercise/tax liability with 459 units of Common Stock, increasing direct ownership by 3% to 32,699 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1834d
  SEC Form 4: Belloff Neil S. exercised 6,250 units of Common Stock at a strike of $0.00 and covered exercise/tax liability with 1,835 units of Common Stock, increasing direct ownership by 16% to 31,595 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1840d
  SEC Form 4 filed by Walts Alan Edmund

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1840d
  SEC Form 4 filed by Nussbaum Ran

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1840d
  SEC Form 4 filed by Avnur Zafrira

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1840d
  SEC Form 4 filed by Seehra Jasbir

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1843d
  SEC Form 4: PAREKH RAJESH B bought $3,329,999 worth of Common Stock (2,466,666 units at $1.35)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1843d
  SEC Form 4: Pontifax Management 4 G.P. (2015) Ltd. bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1843d
  SEC Form 4: Nussbaum Ran bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1843d
  SEC Form 4: Kariv Tomer bought $7,999,999 worth of Common Stock (5,925,925 units at $1.35)

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1857d
  SEC Form 4: Belloff Neil S. exercised 1,562 units of Common Stock at a strike of $0.00 and disposed of $1,001 worth of Common Stock (459 units at $2.18), increasing direct ownership by 4% to 27,180 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1868d
  SEC Form 4 filed by Geffken Daniel E.

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1885d
  SEC Form 4: B Rajesh Parekh was granted 2,532,270 units of Common Stock

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1888d
  SEC Form 4 filed by Edmund Alan Walts

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1888d
  SEC Form 4 filed by Vijay Modur

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1888d
  SEC Form 4 filed by Sumit Aggarwal

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1923d
  SEC Form 4: S. Neil Belloff exercised 25,000 units of Common Stock at a strike of $0.00 and disposed of $28,985 worth of Common Stock (7,338 units at $3.95), increasing ownership by 210% to 26,077 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1923d
  SEC Form 4: C. Gregory Williams exercised 50,000 units of Common Stock at a strike of $0.00 and disposed of $60,672 worth of Common Stock (15,360 units at $3.95), increasing ownership by 347% to 44,629 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1932d
  SEC Form 4 filed by G. Stephen Macdonald

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1932d
  SEC Form 4 filed by S. Neil Belloff

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1932d
  SEC Form 4 filed by C. Gregory Williams

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1947d
  SEC Form 4: S. Neil Belloff exercised 1,563 units of Common Stock at a strike of $0.00 and disposed of $1,864 worth of Common Stock (542 units at $3.44), increasing ownership by 14% to 8,415 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)
• 1947d
  SEC Form 4: C. Gregory Williams disposed of $2,212 worth of Common Stock (643 units at $3.44) and exercised 1,875 units of Common Stock at a strike of $0.00, increasing ownership by 14% to 9,989 units

  4 - Eloxx Pharmaceuticals, Inc. (0001035354) (Issuer)

Other ELOX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends